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Background: Personal recovery (PR) is a subjective, multidimensional concept, and
quantitative research using PR as an outcome is rapidly increasing. This systematic
review is intended to support the design of interventions that contribute to PR in psychotic
disorders, by providing an overview of associated factors and their weighted importance
to PR: clinical factors, social factors, and socio-demographic characteristics are
included, and factors related to the concept of PR (organized into CHIME dimensions).
Methods: A systematic literature search was conducted from inception to March 2020.
Quantitative studies that had used a validated questionnaire assessing the concept of
PR were included. Mean effect sizes for the relationship between PR-scale total scores
and related factors were calculated using meta-analyses. Sources of heterogeneity were
examined using meta-regression tests.
Results: Forty-six studies, that used (a total of) eight PR measures, showed
that in clinical factors, affective symptoms had a medium negative association
with PR-scale total scores (r = −0.44, 95%CI −0.50 to −0.37), while positive,
negative and general symptoms had small negative correlations. No association
was found with neuro-cognition. Social factors (support, work and housing, and
functioning) showed small positive correlations. Gender and age differences had
barely been researched. Large associations were found for PR-scale total scores
with the CHIME dimensions hope (r = 0.56, 95%CI 0.48–0.63), meaning in life
(r = 0.48, 95%CI 0.38–0.58) and empowerment (r = 0.53, 95%CI 0.42–0.63);
while medium associations were found with connectedness (r = 0.34, 95%CI
0.43–0.65) and identity (r = 0.43, 95%CI 0.35–0.50). Levels of heterogeneity were high,
sources included: the variety of PR measures, variations in sample characteristics,
publication bias, variations in outcome measures, and cultural differences.
Leendertse et al. Personal Recovery in Psychotic Disorders
Discussion: Most interventions in mental healthcare aim to reduce symptoms and
improve functioning. With regard to stimulating PR, these interventions may benefit from
also focusing on enhancing hope, empowerment, and meaning in life. The strength of
these findings is limited by the challenges of comparing separate CHIME dimensions
with questionnaires assessing the concept of PR, and by the high levels of heterogeneity
observed. Future research should focus on the interaction between elements of PR and
clinical and social factors over time.
Keywords: subjective recovery, person-oriented recovery, meta-analysis, psychosis, schizophrenia, personal
recovery
INTRODUCTION
Personal recovery (PR) is described as a highly individual process,
whose definition is the subject of a debate that comprises
a large and ever-growing body of literature. Several reviews
have described PR in psychosis as either an idiosyncratic
and non-linear process containing key elements (1–3), or as
both process and outcome (4), or a multi-dimensional concept
whose focus depends on individuals’ experiences (5). Although
consensus on the definition has not yet been reached (6),
a widely endorsed theoretical basis for clinical and research
purposes is offered by the conceptual framework of CHIME, the
acronym for Connectedness, Hope, Identity, Meaning in life, and
Empowerment (7).
When PR is considered an outcome, several validated
questionnaires—such as such as the Recovery Assessment Scale
(RAS) (8), the Questionnaire about the Processes of Recovery
(QPR) (9), and theMental Health Recovery Measure (MHRM)—
can be used to measure PR (10). However, there is no gold
standard (11), and a broad andmultidimensional construct of PR
can sometimes lead to ambiguous interpretations (12).
Quantitative research using PR as an outcome measure is
nonetheless growing rapidly, and recently a call was made
for more research into the ways in which interventions in
specific groups may contribute to PR (6). A previous review
indicated that PR improved over time when people are involved
in recovery-oriented mental health treatment, especially when
professionals collaborate with peer providers (13). Another
recent review aimed to investigate the relationship between
clinical and personal recovery, by performing a meta-analysis
of the association between PR and (positive, negative, and
affective) symptoms and functioning. Their findings suggested
that clinical and personal recovery are only weakly associated,
and that both need their own attention in treatment and outcome
monitoring of people with psychotic disorders (14). The aim of
the current study was to offer an overview of all factors associated
with PR including social factors and demographics. Such an
overview would add value to the development of interventions
for improving PR in psychotic disorders, by giving direction to
which elements to focus on.
The objective was therefore to systematically review and
investigate the strength of the relationship between PR and
associated factors in people with psychotic disorders. In our
original study protocol we set out to look for associated factors
in all quantitative studies assessing PR: interventions studies;
cross-sectional studies; and longitudinal studies. However, when
searching the literature, we came across two observations: firstly,
only a very limited number of intervention studies were available
that used PR as an outcome measure, and in these studies, no
associations between PR-scale total scores and associated factors
were described; and secondly, a large proportion of studies
researched the association between PR-scale total scores and
elements of PR itself (such as stigma and hope). In order to
provide a complete reflection of the current state of literature,
we decided to also include these factors related to the concept




After pre-publishing the study protocol in the PROSPERO
database (CRD42019121727), we conducted a literature search
in Embase, PsychINFO, MEDLINE, Web of Science, Cochrane
Central, and Google Scholar. To describe PR with a broad
array of keywords, we used the following search terms:
(subjective-, OR patient based-, OR consumer based-, OR person
oriented-, OR personal recovery) in combination with the
CHIME dimensions (connectedness, OR hope, OR identity, OR
meaning, OR empowerment) in psychosis (psychosis, OR schizo-
affective, OR schizophrenia) using a validated questionnaire
of personal recovery (questionnaire, OR assessment, OR scale,
OR instrument, OR inventory, OR psychometric). The review
process was based on PRISMA guidelines.
Relevant articles were selected on the basis of the following
inclusion criteria: peer-reviewed studies available in English, full-
text, from inception toMarch 2020; DSMor ICD classifications of
schizophrenia and other psychotic disorders (including affective
psychotic disorders); both cross-sectional and longitudinal
studies that used a validated questionnaire assessing the concept
of PR and reported cross-sectional associations. Articles were
excluded if they met the following exclusion criteria: severe
mental illness (SMI) samples in which <65% of the study
population had a psychotic disorder; use of item scores or
subscale scores of personal recovery questionnaires, rather than
total scores or validated short forms; pilot studies, feasibility
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FIGURE 1 | PRISMA flow diagram of studies including factors associated to personal recovery in psychosis (17).
studies, or implementation studies; and studies that performed
secondary analyses on a sample that had already been included.
Retrieved publications were de-duplicated using EndNote X9
reference-management software. To identify studies that might
meet our inclusion criteria, titles and/or abstracts were screened
by the first rater (PL). Titles that were deemed relevant were
screened independently by two members of the review team (PL
and AR). Any disagreement on eligibility was resolved through
discussion with a third author (DB). The full text of the remaining
articles was screened (by PL) for factors associated with PR.
Data Extraction
Data were extracted from the included studies. They included
sample characteristics (sample size, percentage with a psychotic
disorder); study characteristics (country, study design); the
personal recovery measure used; all factors related to PR,
including the measures used; and the corresponding effect sizes.
Extracted factors were organized into four categories that were
further subdivided into domains: (1) factors related to the
concept of personal recovery (CHIME dimensions); (2) clinical
factors (affective, positive, negative, and general symptoms;
neuro-cognition); (3) social factors (support; work and housing;
psychosocial functioning); (4) and factors not included in the
meta-analysis due to the small number of studies: longitudinal
findings, socio-demographic and other patient characteristics.
For an overview of domains and corresponding factors, see the
Supplementary Table 1.
To assess the strength of the cross-sectional relationship
between factors and PR-scale total scores, we extracted
correlation coefficients or corrected Beta-coefficients at baseline
or T1 from the text or tables of included studies (15). A mean
effect size was calculated for each domain. To ensure that
each study contributed only one correlation per domain to the
analysis, results per domain were averaged. For example, as
stigma and self-esteem were both gathered under the CHIME
dimension “identity,” they were averaged to obtain one overall
correlation for PR-scale total score and identity. To ensure that
all correlations within one factor-domain were interpreted in
the same direction, coefficients were reversed where necessary.
Following Cohen’s convention, coefficients of 0.10, 0.30, and
0.50 were interpreted to demarcate small, medium, and large
effects, respectively.
Statistical Analyses
Metaforpackage in “R” was used to calculate mean effect-sizes
per domain on the basis of random effects models using inverse-
variance weighted Fisher’s Z. Forest plots as visual summaries of
the meta-analyses were inspected. Q-tests were conducted to test
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for evidence of heterogeneity, with I2 statistics as a method to
quantify the level of heterogeneity. The source of heterogeneity
was examined using meta-regression analyses, the predictors
being PR measure and sample characteristics (100% psychotic
disorder or less). To test for publication bias, Egger tests were
used to detect funnel-plot asymmetry, but only if there were
enough studies to perform this test. Sensitivity analyses were
conducted to explore the effects of study quality.
Study Quality
Study quality was independently assessed by two raters (PL and
AW) using the NIH-Quality assessment tool for observational
and cross-sectional studies (16). This tool covers fourteen study
characteristics and was designed to focus on the key concepts for
evaluating the internal validity of a study, including topics such
as study objectives, sample selection, and adequate reporting. To
facilitate sensitivity analysis—i.e., the exclusion of low-quality
papers—the methodological quality of each study was rated as
poor, fair or good. Statistical heterogeneity was reduced after
excluding studies rated as poor; this mainly involved validation
studies or studies in which personal recovery was not the primary
outcome variable. However, point estimates and confidence
intervals were not much affected by the exclusion (details of
meta-analysis, sensitivity analysis, and tests of heterogeneity are
available on request from the first author). To test for publication
bias, Egger’s method was used to detect funnel-plot asymmetry,
but only if there were enough studies to perform this test. If
statistically significant, the trim-and-fill method was used to
explore the effect of publication bias.
RESULTS
Study Characteristics
Of the 2,061 papers found, 1,893 were excluded on the basis
of abstract and title. The full text of the remaining 168 articles
was assessed for eligibility, leading to the exclusion of 125
articles (reasons are shown in Figure 1). Google Scholar was
consulted and reference lists of included studies were hand
searched to check for missing studies, which resulted in three
additional articles. This resulted in 46 studies that were eligible
for inclusion in the review. Study characteristics are described
in Table 1.
Personal Recovery
In total, eight PRmeasures were used: Recovery Assessment Scale
(RAS) (n = 18 studies) (8); Questionnaire about the Process of
Recovery (QPR) (n = 15) (9); Mental Health Recovery Measure
(MHRM) (n= 6) (10); Recovery Style Questionnaire (RSQ) (n=
5) (62); Maryland Assessment of Recovery (MARS) (n = 3) (63);
Recovery Attitudes Questionnaire (RAQ-7) (n = 1) (64); Stages
of Recovery Scale (SRS) (n = 1) (65); and Stages of Recovery
Instrument (STORI) (n = 1) (66). One study used both the
MHRM and RAS.
CHIME Dimensions
Large positive associations with PR-scale total scores were found
for hope (r = 0.56, 95% CI = 0.48–0.63, p < 0.001); meaning in
life (r= 0.48, 95% CI= 0.38–0.58, p< 0.001); and empowerment
(r = 0.53, 95% CI = 0.42–0.63, p < 0.001). Medium positive
associations with PR were found for connectedness (r = 0.34,
95% CI = 0.26–0.42, p < 0.001); and identity (r = 0.43, 95%
CI = 0.35–0.50, p < 0.001). Inspection of the forest plots and
Q-tests for all domains suggested heterogeneity between studies.
I2 tests indicated high levels of heterogeneity for all CHIME
dimensions, which ranged from 73.9 to 93.5% (see Table 2A).
Meta-regression tests indicated differences caused by the use
of the RAS as measure of PR in all the analyses of CHIME
dimensions, although most differences were small and did not
reach significance. One exception was the association between
PR and empowerment, where RAS significantly increased the
positive association (0.34, 95%CI = 0.19–0.48, p < 0.001). Due
to the small number of studies, however, these results should be
interpreted with caution. Heterogeneity can also be attributed
to sample characteristics. Meta-regression indicated that studies
using samples with 100% psychotic disorders (rather than SMI
with >65% psychotic disorders) reduced the association between
PR and meaning in life (−0.38, 95%CI = −0.76 to −0.00,
p = 0.05); PR and empowerment (−0.24, 95% CI = −0.65–
0.17, p = 0.25); and PR and connectedness (−0.14, 95%CI
= −0.34–0.05, p = 0.16). One exception was the increased
association between PR and identity (0.21, 95%CI = −0.14–
0.55, p = 0.24). None of these results reached significance.
In addition, results for connectedness and empowerment were
based on a small number of studies. In the studies investigating
the association between PR-scale total scores and hope, the
regression test for funnel-plot asymmetry indicated publication
bias (z = 3.970, p < 0.001). For the results of the meta-
analyses and tests of heterogeneity, see Table 2A. For forest plots,
see the Supplementary Table 2.
Clinical Factors
A medium negative association with PR-scale total scores was
found for affective symptoms (r = −0.44, 95% CI = −0.50 to
−0.38, p < 0.001). Small negative associations with PR-scale
total scores were found for positive symptoms (r = −0.22,
95% CI = −0.28 to −0.15, p < 0.001); negative symptoms
(r = −0.22, 95% CI = −0.28 to −0.16, p < 0.001); and
general symptoms (r = −0.26, 95% CI = −0.37 to −0.15, p
< 0.001). I2 scores ranged from 65.5 to 90.0%, indicating that
the proportion of the total variance explained by heterogeneity
was moderate to high. There was an indication of publication
bias in the association between PR-scale total scores and positive
symptoms (z = −2.27, p = 0.023). The trim-and-fill method
showed a relatively small reduction (0.3) of the correlation
estimate. Meta-regression analysis indicated that the use of the
QPR increased the negative association between PR-scale total
scores and all symptom domains (affective, positive, negative, and
general symptoms). No association with PR-scale total scores was
found for neuro-cognition (r = 0.05, 95%CI = −0.12 to 0.22,
p = 0.536). Although only a moderate degree of heterogeneity
between studies on PR and neuro-cognition was found (I2 =
72%), examination of the forest plot showed that there were
outliers in both directions. For the results of the meta-analyses
and tests of heterogeneity, see Table 2B. For forest plots, see
Supplementary Table 2.
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TABLE 1 | Study characteristics of included studies (n = 46) in meta-analysis about associated factors with personal recovery in psychosis.
References N (% psychotic
disorders)




Andresen et al. (10) 110 (100%) Cross-sectional Australia RAS, MHRM GAF, HoNOS, LSP, K10
Armstrong et al. (18) 795 (100%) Cross-sectional US MHRM LQoLI, CSQ-8, BPRS, MIRECC-GAF
Beck et al. (19) 122 (100%) Cross-sectional UK QPR HADS, BHS, SERS
Bhullar et al. (20) 65 (100%) Longitudinal UK, Canada MARS LCS
Boggian et al. (21) 216 (100%) Cross-sectional Italy RAS SESM, RSE, MANSA, HoNOS
Browne et al. (22) 404 (100%) Longitudinal USA MHRM QLS, SPWB
Brunet-Gouet et al.
(23)
34 (100%) Cross-sectional France STORI V-MSEQ
Chan et al. (24) 181 (100%) Longitudinal China RAS SAPS, SANS, SOFAS, UPSA,
MHC-SF
Chien and Chan (25) 300 (100%) Cross-sectional China QPR SQLS, SLOF, PSES
DeTore et al. (26) 404 (100%) Cross-sectional USA MHRM SCID-1, TLEQ
Erim et al. (27) 100 (100%) Cross-sectional Turkey RAS y/n question employment status
Espinosa et al. (28) 50 (100%) Cross-sectional Spain RSQ ISMI, BDI, BAI
Giusti et al. (29) 76 (100%) Cross-sectional Italy RAS BPRS, PANSS, PSP, RAVLT, Raven
CPM, TMT, Weigl CFST, BCIS, IS
Gruber et al. (30) 138 (100%) Cross-sectional Germany RSQ WHOQOL-BREF, ISMI, SE, KK, ES
Guler and Gurkan (31) 180 (65%) Cross-sectional Turkey RAS PWS
Hasson-Ohayon et al.
(32)
80 (100%) Cross-sectional Israel RAS SCC, ISMI, LRI
Hasson-Ohayon et al.
(33)
107 (>80%) Cross-sectional Israel RAS ISMI, IS, SCC, RFQ, ADHS
Hicks et al. (34) 61 (100%) Longitudinal Australia RAS WAI-S, ADHS
Ho et al. (35) 204 (100%) Cross-sectional China RAQ-7 HCCQ, MOSS-C-EIS,
WHOQOL-BREF, WHOQOL-SRPBS,
MSPSS-C, ASHS, ESCA, ISMI, RS,
MS, SQLS, MDES
Jahn et al. (36) 169 (100%) Cross-sectional USA MARS BSI, PANSS (positive, negative)
Jorgensen et al. (37) 101 (100%) Longitudinal Denmark RAS PANSS
Kukla et al. (38) 113 (100%) Cross-sectional USA RAS PAM, PANSS, MS1, ASHS, IMR-S
Lavin and Ryan (39) 63 (67%) Cross-sectional Ireland RAS PWS, ASHS
Law et al. (40) 335 (100%) Cross-sectional UK QPR PANSS, Psyrats, BHS, SERS,
CDSS, PSP
Lim et al. (41) 66 (100%) Cross-sectional Signapore QPR HHI, ISMI, ES, PANSS, CDSS, PSP,
WHOQOL-BREF, RSWB
Mathew et al. (42) 80 (100%) Cross-sectional India RAS PANSS, SUBI, GAF
McLeod et al. (43) 89 (100%) Cross-sectional Australia QPR SEPRS, ISMI, involuntary treatment
(y/n), contact recovered peers
(high/low)
Morrison et al. (44) 122 (100%) Cross-sectional UK QPR HADS, SERS, IS, PANSS, MLCS,
BACS
Mueser et al. (45) 399 (100%) Cross-sectional USA MHRM SS
O’Keeffe et al. (46) 171 (100%) Longitudinal Ireland RAS CD-RISC
Roe et al. (47) 159 (100%) Cross-sectional Israel RAS BPRS, GAF, MSPSS, S-SELAS,
Mansa
Rossi et al. (48) 903 (100%) Cross-sectional Italy RSQ PANSS, PSP
Song (49) 592 (74.7%) Cross-sectional Taiwan SRS RPRS
Stainsby et al. (50) 50 (100%) Longitudinal UK RSQ IPQ-S, Mansa, LSP
Temesgen et al. (51) 263 (100%) Cross-sectional Ethiopia QPR PANSS, BHS, SSQ, ISMI, WHODAS,
WHOQOL-BREF
Thomas et al. (52) 250 (100%) Cross-sectional USA MARS SSQ, ROSI, SEES< BSI, SFS
Van der Krieke et al.
(53)
581 (100%) Cross-sectional Netherlands RAS WHOQOL-BREF, PANSS, SFS,
CAN, RSQ
(Continued)
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TABLE 1 | Continued
References N (% psychotic
disorders)




van Eck et al. (54) 105(76.6%) Cross-sectional Netherlands MHRM BPRS-E
Vass et al. (55) 80 (100%) Longitudinal UK QPR KSS, SERS, BHS, PANSS
Vass et al. (56) 59 (100%) Cross-sectional UK QPR KSS, ISMI, SERS, PANSS
Vogel et al. (12) 52 (100%) Cross-sectional Netherlands MHRM SSL-12-I
Williams et al. (57) 65 (100%) Cross-sectional Canada RAS BPRS, SAI, ISMI, BHS
Wood and Irons (58) 52 (100%) Cross-sectional UK QPR SS, OAS, SCS, PANSS (-positive),
CDSS, BAI
Wood et al. (59) 79 (100%) Cross-sectional UK QPR SIMS-E, SIMS-P, ISS, SERS, BDI,
BHS
Wright et al. (60) 62 (100%) Cross-sectional USA QPR MAI, TMT, BCIS, Metacognition
(-appraisal task, detection task),
WASI, UPSA, TUS, PANSS (neg,
anxiety, depression), SSI-AE
Zizolfi et al. (61) 44 (100%) Cross-sectional Italy RSQ RS, MoCA, PANSS, LSP, SQLS
ADHS, adult dispositional hope scale; ASHS, adult state hope scale; BACS, brief assessment of cognition in schizophrenia; BAI, beck anxiety inventory; BDI, beck depression inventory;
BCIS, beck cognitive insight scale; BHS, beck hopelessness scale; BPRS, brief psychiatric rating scale; BPRS-E, BPRS expanded version; BSI, brief symptom inventory; CAN,
camberwell assessment of needs; CD-RISC, Connor–Davidson resilience scale; CDSS, calgary depression scale for schizophrenia; CSQ-8, client satisfaction questionnaire; ES, Rogers
empowerment scalel ESCA, exercise of self care agency; GAF, global assessment of functioning; HADS, hospital anxiety and depression scale; HCCQ, health care climate questionnaire;
HHI, herth hope index; HoNOS, health of the nation outcome scales; IMR-S, illness management and recovery scale; IPQ-S, illness perceptions questionnaire for schizophrenia; IS,
insight scale; ISS, internalized shame scale; ISMI, internalized stigma of mental illness; K10, Kessler psychological distress scale; KK, krankheitskonzept skala (illness concept scale);
KSS, king stigma scale; LCS, life chart schedule; LSP, life skill profile; LQoLI, Lehman quality of life interview; LRI, life regard index; MANSA, Manchester assessment quality of life;
MAI, metacognitive assessment interview; MDES, making decision empowerment scale; MHC-SF, mental health continuum-short form; MIRECC-GAF, mental illness research education
and clinical centers version of the global assessment of functioning scale; MLCS, multidimensional locus of control scale; MOSS-C-EIS, emotional informational support scale of the
medical outcome study social support survey chinese version; MS, mastery scale; MS1, morisky scale (of medication adherence); MoCA, montreal cognitive assessment; MSPSS,
multidimensional scale of perceived social support; MSPSS-C, MSPSS–Chinese version; OAS, other as shamer scale; PAM, patient activation measure; PANSS, positive and negative
syndrome scale; PANSS-positive, PANSS positive symptoms subscale; PANSS-negative, PANSS negative symptoms subscale; PANSS-GP, PANSS general psychopathology subscale;
PSES, perceived elf-efficacy scale; PSP, personal and social performance scale; Psyrats, psychotic symptom rating scales; PWS, psychological well-being scale; QLS, quality of life scale;
Raven CPM, Raven colored progressive matrices; RAVLT, Rey auditory verbal learning test; RFQ, functioning questionnaire; ROSI, recovery oriented system indicator; RS, resilience
scale; RSE, Rosenberg self-esteem; RSQ, recovery style questionnaire; RSWB, Ryff scales of well-being; SAI, schedule for assessing insight; SANS, scale for the assessment of negative
symptoms; SAPS, scale for the assessment of positive symptoms; SCC, self-concept clarity scale; SCID-1, structured clinical interview for axis I DSM–IV disorders; SEES, self-efficacy
scale; SCS, social comparison scale; SE, self-esteem scale by rosenberg; SEPRS, self-efficacy for personal recovery scale; SERS, brief self-esteem rating scale; SESM, empowerment
scale; SFS, social functioning scale; SIMS-E, semi-structured interview measure of stigma- experienced stigma subscale; SIMS-P, SIMS- perceived stigma subscale; SLOF, specific
level of functioning scale; SSI-AE, Schizotypal symptom inventory - anomalous experiences; SSL-12-I, social support list 12 interactions; SOFAS, social and occupational functioning
assessment scale; SPWB, scales of psychological well-being; SQLS, schizophrenia quality of life scale; SS, stigma scale; S-SELAS, social and emotional loneliness scale—short version;
SSQ, social support questionnaire; SUBI, subjective well-being inventory; TLEQ, traumatic life events questionnaire; TMT, trail making test; TUS, time use survey; UPSA, University of
California, San Diego, Performance-Based Skills Assessment; V-MSEQ, versailles metacognitive strategies evaluation questionnaire; WAI-S, working alliance inventory—short form;
WASI, Wechsler abbreviated scale of intelligence; Weigl CFST, Weigl’s color form sorting test; WHODAS, world health organization disability assessment schedule; WHOQOL-BREF,
world health organization quality of life—BREF version; WHOQOL-SRPBS, WHOQOL spirituality religion and personal belief scale.
Social Factors
Small positive associations were found between PR-scale total
scores and support (r = 0.28, 95% CI = 0.20–0.36, p <
0.001); work and housing (r = 0.23, 95% CI = 0.00–0.44,
p = 0.046); and psychosocial functioning (r = 0.31, 95%
CI = 0.21–0.41, p < 0.001). There was a high degree of
heterogeneity between studies in the association between PR-
scale total scores and psychosocial functioning (I2 = 92.5%)
that was not attributable to variation in sample characteristics
or type of PR measure. In the association between PR-scale
total scores and support, the degree of heterogeneity was low
(I2 = 35.2%). The meta-regression test indicated that the
positive association was reduced by the use of the QPR. The
number of studies investigating the association of PR and
work and housing was too small for meaningful interpretation
of analyses of heterogeneity. For results of the meta-analyses
and tests of heterogeneity, see Table 2C. For forestplots,
see Supplementary Table 2.
Other Factors
Few studies reported on effects of socio-demographic and patient
characteristics. Five studies investigated the relationship between
age and PR-scale total scores (19, 29, 36, 39, 56), only one of
which found a small (negative) association (r=−0.23, p < 0.05),
indicating that older age was related to lower PR (19). One study
investigated the relationship between gender and PR-scale total
scores (56), and another investigated the relationship between
education and PR-scale total scores (36); both found negligible
differences. Other studies reported no significant differences
in PR-scale total scores for years of illness (29), medication
adherence (38), contact with recovered peers (43), or involuntary
treatment (43). However, PR-scale total scores were found to be
positively associated with physical health (r = 0.30, p < 0.001)
(35). A negative association was found for PR-scale total scores
with a diagnosis of comorbid PTSD (r = −0.13, p = 0.01) (26).
PR-scale total scores were also found to be negatively associated
with type of diagnosis (schizophrenia or bipolar disorder) (r =
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TABLE 2A | Meta-analysis results and tests of heterogeneity for CHIME dimensions.
CHIME dimensions K Mean ES 95%CI Homogeneity (Q, df) I2
Connectedness 7 0.34 0.26–0.42 Q(df = 6) = 26.5846, p = 0.0002 73,9%
Hope 12 0.56 0.48–0.63 Q(df = 11) = 47.6065, p < 0.0001 77.1%
Identity 25 0.43 0.35–0.50 Q(df = 24) = 189.3599, p < 0.0001 85.7%
Meaning 17 0.48 0.38–0.58 Q(df = 16) = 192.1816 p < 0.0001 93.5%
Empowerment 60 0.53 0.42–0.63 Q(df = 5) = 21.5806, p = 0.0006 74.2%
K, number of studies in de analysis; Mean ES, pooled effect size of the individual studies; Q-test, test for homogeneity, significant Q-tests indicate heterogeneity; I2, quantification of
heterogeneity, 25% indicating low heterogeneity, 50% moderate, and 75% high heterogeneity.
TABLE 2B | Meta-analysis results and tests of heterogeneity for clinical factors.
Clinical factors K Mean ES 95%CI Homogeneity (Q, df) I2
Affective symptoms 13 −0.44 −0.50 to −0.37 Q(df = 12) = 32.964, p = 0.0010 65.5%
Positive symptoms 19 −0.22 −0.28 to −0.15 Q(df = 18) = 61.598, p < 0.0001 75.3%
Negative symptoms 18 −0.22 −0.28 to −0.16 Q(df = 17) = 63.386, p < 0.0001 70.2%
General symptoms 15 −0.26 −0.37 to −0.15 Q(df = 14) = 124.783, p < 0.0001 90.0%
Neurocognition 7 −0.05 −0.12 to 0.22 Q(df = 6) = 18747, p < 0.0046 72.1%
−0.41, p < 0.01), indicating that having a non-affective psychotic
disorder is related to lower PR-scale total scores as compared to
an affective psychotic disorder (56).
Few studies reported on longitudinal findings. Three studies
investigated the relationship between duration of untreated
psychosis (DUP) or untreated illness (DUI) and PR-scale total
scores over follow-up periods ranging from over 2 years, to 10 or
20 years (20, 22, 46). Overall, results were inconclusive although
some negative associations were reported. In one study a non-
affective psychotic disorder was found to be related to lower PR-
total scores over 20 years as compared to an affective psychotic
disorder, while lifetime substance abuse was not related (56).
Another study reported on the associations of PANSS-subscales
and PR-scale total scores at baseline and after 3, 6, and 12
months (37): no statistically significant correlations were found
for the Cognitive scale, whereas only the Emotional Discomfort
Component showed medium to strong negative correlation
coefficients at all four time points. No associations were found
between PR-scale total scores and illness perception or quality
of life over 2 years (50). Some other studies reported on positive
correlation coefficients over a 6 month period for well-being (24),
working alliance (34), and perceived stigma (55).
DISCUSSION
The aim of this systematic review and meta-analysis is to
provide an overview of factors associated with PR-scale total
scores in people with a psychotic disorder. In our original
study protocol we planned to include intervention studies,
however the literature search revealed that the few available
intervention studies did not report cross-sectional associations
with PR. Furthermore, we found that a large proportion of
studies researched the association between PR-scale total scores
and elements of PR itself. We decided to include these as well,
and to organize them into CHIME dimensions. Unsurprisingly,
considering the overlap, the associations between PR-scale
total scores and the CHIME dimensions were medium to
large. This overlap is confirmed by the fact that some
studies investigated PR-scale total scores in relation to CHIME
dimensions in order to assess the convergent validity of a PR
measure (21, 25, 30, 31, 40, 41, 49).
Large positive associations with PR-scale total scores were
found for meaning in life, empowerment and hope, whereas
medium associations were found for identity and connectedness.
This is in line with qualitative studies, which indicated that PR
from the point of view of people with psychotic disorders can be
defined in terms of faith, hope, agency and spirituality (3).
As determinants of PR-scale total scores, only affective
symptoms appeared to have a medium negative association. All
other factors showed either small negative associations (positive,
negative, and general symptoms), or small positive associations
(support, work and housing, and psychosocial functioning). No
association was found with neuro-cognition, and the relatively
small number of studies that investigated sociodemographic
characteristics found no uniform effect for age.
However, interpretation of these associations was impeded
by heterogeneity between studies in almost all domains. This
heterogeneity had several sources, one being the variety of PR
measures. As PR is a highly subjective concept, variation in PR
measures is inevitable. We found that the QPR was linked more
strongly to the symptom domains, while the RAS was linked
more strongly to the CHIME dimensions. The RAS is known to
have a particular emphasis on hope and self-determination (8);
this may offer one explanation for the fact that its use reinforces
the positive association between CHIME dimensions and PR-
scale total scores. Another explanation for the high levels of
heterogeneity may lie in the influence of heterogeneity in the
study sample (SMI with >65% psychosis, rather than samples
with 100% psychotic disorder). There was also evidence for
publication bias in the associations between PR-scale total scores
and the domains positive symptoms and hope, although the
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TABLE 2C | Meta-analysis results and tests of heterogeneity for social factors.
Social factors K Mean ES 95%CI Homogeneity (Q, df) I2
Support 5 0.28 0.22–0.36 Q(df = 4) = 6.059, p < 0.1948 35.2%
Work and housing 3 0.23 0.00–0.44 Q(df = 2) = 11.788, p < 0.0028 82.4%
Psychosocial functioning 20 0.31 0.21–0.41 Q(df = 19) = 224.287, p < 0.0001 92.7%
trim-and-fill method indicated only a small effect of publication
bias on the associations.
Variation in the independent variables may also have
contributed to the level of heterogeneity. This was illustrated,
for example, in the domain of neuro-cognition, which consisted
of neuropsychological tests, observer-rated neurocognitive
functioning, and self-rated metacognitive functioning. Similarly,
in the domain of psychosocial functioning, GAF appeared to
be more weakly associated with PR-scale total scores compared
to other scales of psychosocial functioning. Previous research
suggested that this was due to the fact that GAF comprises
both functioning and symptoms (14). Cultural values are also
likely to play a role in a subjective construct such as PR (12, 67).
Between different countries, for example, large differences have
been found in the associations between PR-scale total scores and
meaning in life (21, 31, 39, 47).
Limitations
We used the CHIME model (7) in our literature search as a
framework for PR. However, there are also other frameworks for
PR, such as the SAMHSA statement, which offers 10 recovery
components as essential mediators of recovery (68). Although,
like CHIME, this aims to enhance recovery in mental health, we
chose CHIME because it is widely endorsed (6), and because one
of the purposes of the framework is to provide keywords for use
in systematic reviewing (7).
The literature search limited to peer-reviewed studies available
in English, which may not represent all of the evidence and may
have introduced a language bias.
When certain factors were combined, detailed information on
individual factors may have been lost. For example, this may have
happened when averaging the correlation of stigma, and self-
esteem with PR-scale total scores, in order to obtain one effect
size per study for the CHIME dimension “identity”.
Studies in which <65% of the study population had a
psychotic disorder were excluded from the analysis. This
percentage was based on expert opinion only, since a clear cut-
off point could not be found in guidelines or previous research.
To further objectify this decision, sample characteristics (100%
psychotic disorder or less) was included as a predictor in the
meta-regression analysis, but results indicated no significant
differences because of variation in sample characteristics.
Implications for Future Research
This review is consistent with previous research showing that,
in psychotic disorders, symptoms and PR are weakly related,
with affective symptoms showing medium associations and
all other symptom domains showing small associations (14).
Social factors and the (partly overlapping) CHIME dimension
“connectedness” showed weaker associations with PR-scale total
scores than expected. Previous qualitative research indicated that
support, social inclusion and recovery-oriented practices (which
are known to focus on these themes), are the main facilitators
of PR (2, 6). In line with this, recent research on recovery-
oriented interventions suggested that PR is mutually beneficial
to functional domains (e.g., employment, education, housing)
and social domains (e.g., social functioning and support, and
community integration), meaning that gains in one domain
can contribute to gains in another (69). However, quantitative
studies in people with psychotic disorders have paid relatively
little attention to the association of PR with these domains. In
fact, as the three factors included in the domain of work and
housing all concerned employment, we could not examine the
independent effect of housing on PR. We therefore suggest that
future research should focus on the relationship between PR and
a greater number of social factors (e.g., support in employment
and housing, and community integration) and between PR and
connectedness (e.g., working relationship, social network, and
level of perceived support).
Our meta-analysis focused on cross-sectional correlations
since few longitudinal studies were included. However,
longitudinal findings of PR in SMI were in line with our own
findings, suggesting that without an explicit focus on recovery-
oriented principles (e.g., personal goals, needs and strengths and
a collaborative working relationship), mental health services
are unlikely to affect PR (13). Nevertheless, more research is
needed into the interaction between elements of PR and clinical
and social factors over time. In line with previous research
(12–14), we also suggest that future research would benefit from
consensus on a PR measure.
Implications for Clinical Practice
A multifactorial approach to improving PR in psychosis
appears to be indicated. Many treatments for psychotic disorder
patients focus on reducing psychotic symptoms and improving
functioning. Previous research underlined the weak associations
between elements of clinical recovery (except for affective
symptoms) and PR (14). Likewise, our study suggests only
weak associations with social factors like support, work, and
feeling connected, which were expected to be important domains
of PR in psychotic disorder. Only three CHIME dimensions,
i.e., meaning in life, empowerment, and hope, showed strong
associations with PR-scale total scores, in contrast to the other
two dimensions: connectedness and identity. Therefore, we
suggest on the basis of the cross-sectional results of our study
that if we wish to enhance PR, treatments should focus on
affecting the elements of PR itself. PR is a multidimensional
construct, and most PR interventions focus on more dimensions.
However, meaning in life, empowerment, and hope seem to be
the dimensions to focus on. In addition, symptoms and their
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associated distress should be approached with evidence-based
psychological treatment (70, 71), with a particular emphasis on
negative affect. Little is known about how these factors might
influence each other: for example, having hope may reinforce
the effectiveness of treatment in reducing distress associated with
symptoms of psychosis, and the reduction of distress associated
with symptoms may reinforce having hope for the future.
There are empirically validated interventions for each of
these PR elements. Meaning in life for example is supported
by narrative-enhanced cognitive therapy (72), and can involve
post-traumatic growth (73). With regard to subjective quality
of life (SQOL)—a concept pertaining to the CHIME dimension
“meaning in life”—previous research also stressed the association
with negative affect in people with psychotic disorders, proposing
that treatment plans for improving SQOL should focus on
feelings of guilt, insecurity or anxiety (74). Meaning in life
is also about spirituality. A recent review emphasized the
significant role of spirituality in the lives of mental-health
service users, and the importance for professionals not only
of being aware of spirituality, but also of supporting it (75).
Empowerment is an increasing focus for clinician-delivered
interventions (76) and peer-delivered support (77); it is also a
focus for the movement toward rights-oriented mental-health
systems (78). Finally, peer support work is an established and
highly researched approach to supporting hope (79, 80). On
the basis of their review of longitudinal findings of PR in
SMI, Thomas et al. (13) suggested that PR should be promoted
by including themes such as self-management skills and self-
determination as standard components of mental health services.
However, implementing recovery-oriented practices into routine
mental health is challenging (6). Implementation is influenced by
organizational values and priorities, and culture. One illustration
of this is the fact that well-designed interventions such as
REFOCUS increase PR only when they are properly implemented
(81, 82).
CONCLUSIONS
Overall, in view of the tautological question of comparing PR
with PR elements, and also of the high levels of heterogeneity
between studies, we speculate with some caution that when one
seeks to improve PR in psychosis, an emphasis on enhancing
meaning in life, empowerment and hope, in addition to
symptom reduction and improvement of functioning, might
lead to better outcome. Future research should focus on the
interaction between elements of PR and clinical and social
factors, e.g., how hope and changes in symptoms due to
effective treatment influence each other over time, and more
research is needed into the relationship between PR and
social factors.
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